172 related articles for article (PubMed ID: 26675354)
1. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma.
Feldmeyer L; Tetzlaff M; Fox P; Nagarajan P; Curry J; Ivan D; Torres Cabala CA; Prieto VG; Aung PP
Am J Dermatopathol; 2016 Jul; 38(7):484-91. PubMed ID: 26675354
[TBL] [Abstract][Full Text] [Related]
2. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.
Bayram A; Ozturk Sari S; Ozluk Y; Tas F; Buyukbabani N
J Cutan Pathol; 2021 Apr; 48(4):472-478. PubMed ID: 32935876
[TBL] [Abstract][Full Text] [Related]
3. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34.
Rose AE; Christos PJ; Lackaye D; Shapiro RL; Berman R; Mazumdar M; Kamino H; Osman I; Darvishian F
Am J Surg Pathol; 2011 Oct; 35(10):1441-9. PubMed ID: 21881483
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral and peritumoral lymphovascular invasion detected by D2-40 immunohistochemistry correlates with metastasis in primary cutaneous Merkel cell carcinoma.
Al-Rohil RN; Milton DR; Nagarajan P; Curry JL; Feldmeyer L; Torres-Cabala CA; Ivan D; Prieto VG; Tetzlaff MT; Aung PP
Hum Pathol; 2018 Jul; 77():98-107. PubMed ID: 29601841
[TBL] [Abstract][Full Text] [Related]
7. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
Niakosari F; Kahn HJ; Marks A; From L
Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
10. [Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].
Martini T; Ströbel P; Steidler A; Petrakopoulou N; Erben P; Bolenz C
Urologe A; 2015 Jan; 54(1):70-5. PubMed ID: 25391439
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status.
Aung PP; Leone D; Feller JK; Yang S; Hernandez M; Yaar R; Singh R; Helm T; Mahalingam M
Hum Pathol; 2015 Feb; 46(2):304-12. PubMed ID: 25537974
[TBL] [Abstract][Full Text] [Related]
12. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
13. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
[TBL] [Abstract][Full Text] [Related]
14. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.
Storr SJ; Safuan S; Mitra A; Elliott F; Walker C; Vasko MJ; Ho B; Cook M; Mohammed RA; Patel PM; Ellis IO; Newton-Bishop JA; Martin SG
Mod Pathol; 2012 Apr; 25(4):493-504. PubMed ID: 22080065
[TBL] [Abstract][Full Text] [Related]
15. Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer.
Britto AV; Schenka AA; Moraes-Schenka NG; Alvarenga M; Shinzato JY; Vassallo J; Ward LS
BMC Cancer; 2009 Apr; 9():109. PubMed ID: 19356249
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.
Petersson F; Diwan AH; Ivan D; Gershenwald JE; Johnson MM; Harrell R; Prieto VG
J Cutan Pathol; 2009 Nov; 36(11):1157-63. PubMed ID: 19222695
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion as a prognostic factor in melanoma.
Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
[TBL] [Abstract][Full Text] [Related]
18. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer.
Arnaout-Alkarain A; Kahn HJ; Narod SA; Sun PA; Marks AN
Mod Pathol; 2007 Feb; 20(2):183-91. PubMed ID: 17206106
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
